Olema Pharmaceuticals, Inc. (OLMA) Misses Q2 EPS by 6c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.61), $0.06 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue
• Cascadero Copper to sell subsidiary to Lumina Copper for up to $19M